We are live on
!
Find out more
ACM
Atika Capital Management Portfolio holdings
AUM
$796M
1-Year Est. Return
167.57%
This Fund
S&P 500
This Quarter
Est. Return
-13.06%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$340M
AUM Growth
-$218M
(-39%)
Cap. Flow
-$143M
Cap. Flow
% of AUM
-42.21%
Top 10 Holdings %
Top 10 Hldgs %
34.54%
Holding
111
New
25
Increased
14
Reduced
28
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
COUP
Coupa Software Incorporated
COUP
|
+$4.05M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$3.23M |
| 3 |
Vulcan Materials
VMC
|
+$3.14M |
| 4 |
Vanda Pharmaceuticals
VNDA
|
+$3.06M |
| 5 |
iRhythm Holdings
IRTC
|
+$2.54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HubSpot
HUBS
|
+$9.06M |
| 2 |
Shake Shack
SHAK
|
+$6.55M |
| 3 |
PVTL
Pivotal Software, Inc.
PVTL
|
+$6.46M |
| 4 |
WWE
World Wrestling Entertainment
WWE
|
+$5.8M |
| 5 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
+$5.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.3% |
| 2 | Technology | 15.08% |
| 3 | Communication Services | 7.07% |
| 4 | Consumer Discretionary | 6.11% |
| 5 | Materials | 2.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GOOS
51
CALL
Canada Goose Holdings
GOOS
$861M
| $2.56M | 0.75% |
+58,500
| New | +$3.26M |
|
52
Arista Networks
ANET
$248B
| $2.53M | 0.74% |
192,000
+40,000
| +26% | +$575K |
|
|
53
iRhythm Holdings
IRTC
$4.09B
| $2.33M | 0.69% |
+33,500
| New | +$2.54M |
|
|
SIEN
54
DELISTED
Sientra, Inc.
SIEN
| $2.31M | 0.68% |
18,200
-7,460
| -29% | -$1.39M |
|
|
VAR
55
CALL
DELISTED
Varian Medical Systems, Inc.
VAR
| $2.27M | 0.67% |
+20,000
| New | +$2.29M |
|
56
CALL
Madrigal Pharmaceuticals
MDGL
$11.9B
| $2.25M | 0.66% |
+20,000
| New | +$3.1M |
|
57
CALL
Insulet
PODD
$9.23B
| $2.22M | 0.65% |
+28,000
| New | +$2.37M |
|
|
58
Insulet
PODD
$9.23B
| $2.22M | 0.65% |
28,000
-21,000
| -43% | -$1.78M |
|
59
NovoCure
NVCR
$1.87B
| $2.03M | 0.6% |
60,500
-136,500
| -69% | -$4.99M |
|
60
CALL
Roku
ROKU
$21.8B
| $1.84M | 0.54% |
+60,000
| New | +$2.83M |
|
61
PUT
PetMed Express
PETS
$42.1M
| $1.63M | 0.48% |
+70,000
| New | +$1.87M |
|
62
Centene
CNC
$33.1B
| $1.56M | 0.46% |
27,000
-53,000
| -66% | -$3.55M |
|
|
XYZ
63
CALL
Block Inc
XYZ
$50.1B
| $1.51M | 0.45% |
+27,000
| New | +$1.91M |
|
|
ZGNX
64
DELISTED
Zogenix, Inc.
ZGNX
| $1.46M | 0.43% |
40,000
-11,000
| -22% | -$450K |
|
|
65
CALL
BioMarin Pharmaceuticals
BMRN
$11.6B
| $835K | 0.25% |
9,800
-42,100
| -81% | -$4M |
|
|
ZEN
66
DELISTED
ZENDESK INC
ZEN
| $759K | 0.22% |
+13,000
| New | +$749K |
|
|
PTLA
67
CALL
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $585K | 0.17% |
30,000
+5,000
| +20% | +$103K |
|
|
DBD
68
PUT
DELISTED
Diebold Nixdorf Incorporated
DBD
| $498K | 0.15% |
+200,000
| New | +$717K |
|
|
MDCO
69
CALL
DELISTED
Medicines Co
MDCO
| $423K | 0.12% |
22,100
-160,400
| -88% | -$3.73M |
|
70
Moderna
MRNA
$22.5B
| $153K | 0.05% |
+10,000
| New | +$164K |
|
71
Autodesk
ADSK
$50.7B
| – | – |
-14,000
| Closed | -$2.19M |
|
72
AdvanSix
ASIX
$540M
| – | – |
-40,000
| Closed | -$1.36M |
|
73
Bio-Rad Laboratories Class A
BIO
$9.31B
| – | – |
-16,500
| Closed | -$5.16M |
|
|
BLUE
74
DELISTED
bluebird bio
BLUE
| – | – |
-1,397
| Closed | -$2.64M |
|
75
CALL
Bristol-Myers Squibb
BMY
$130B
| – | – |
-75,000
| Closed | -$4.66M |
|
Similar funds
AGA
ACM
LSA
GWA
HP
SC
LWM
NW
Atika Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, Atika Capital Management held 111 positions worth $340M, down 39% from $558M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Atika Capital Management withdrew a net $143M in Q4 2018, closing 40 positions and reducing 28 holdings. Its most notable exit was HubSpot, an estimated $9.06M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 37% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Atika Capital Management opened a new position in Coupa Software Incorporated worth $4.02M.
- Atika Capital Management's largest Q4 2018 buy was Coupa Software Incorporated: 64,000 shares worth $4.02M.
- Atika Capital Management added most to eHealth in Q4 2018, an estimated $2.5M increase.
- Atika Capital Management's biggest Q4 2018 reduction was NovoCure, cutting an estimated $4.99M.
- Atika Capital Management fully exited HubSpot in Q4 2018, selling an estimated $9.06M.
- Atika Capital Management's ten largest holdings make up 35% of its $340M portfolio in Q4 2018.
- Atika Capital Management opened 25 new positions and closed 40 in Q4 2018.
- Atika Capital Management's portfolio value fell 39% quarter-over-quarter to $340M.
Based on Atika Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.